Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders

8 Dec 2015

Abstract excerpt

The objective of this study was to determine whether proteomic profiling in serum samples can be utilized in identifying and differentiating mood disorders. A consecutive sample of patients with a confirmed diagnosis of unipolar (UP n=52) or bipolar depression (BP-I n=46, BP-II n=49) and controls (n=141) were recruited. A 7.5-ml blood sample was drawn for proteomic multiplex profiling of 320 proteins utilizing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bipolar Disorder and Treatment
Share to Tryptophan and brain disorders
Share to Vitamin D Research Studies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26645624
DOI: 10.1038/tp.2015.185

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 25 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disordersPMID 26645624Read ↗

Proteomic approaches to identify blood-based biomarkers for depression and bipolar disordersSemantic proximity Read ↗

Advancing Depression Management Through Biomarker Discovery with a Focus on Genetic and Epigenetic Aspects: A Comprehensive Study on Neurobiological, Neuroendocrine, Metabolic, and Inflammatory PathwaysSemantic proximity Read ↗

Uncovering plasma protein biomarkers linked to depression: A differential abundance analysis and Mendelian randomization using large-scale data.Semantic proximity Read ↗

The role of proteomics in depression researchSemantic proximity Read ↗

Cerebrospinal Fluid Proteome Evaluation in Major Depressive Disorder by Mass SpectrometrySemantic proximity Read ↗

A review of new insights into existing major depressive disorder biomarkersSemantic proximity Read ↗

Untargeted plasma proteomics and clinical phenotypes in adolescent depressionSemantic proximity Read ↗

Identifying circulating biomarkers for major depressive disorderSemantic proximity Read ↗

Major depressive disorder, neuroticism, suicidal behaviors, and depression severity are all associated with neurotoxic immune networks and their intricate interactions with metabolic syndromeSemantic proximity Read ↗

Major depressive disorder, neuroticism, suicidal behaviors, and depression severity are all associated with neurotoxic immune networks and their intricate interactions with metabolic syndrome.Semantic proximity Read ↗

Major depressive disorder: insight into candidate cerebrospinal fluid protein biomarkers from proteomics studiesSemantic proximity Read ↗

Higher immune-related gene expression in major depression is independent of CRP levels: results from the BIODEP studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.